Japan's health ministry approved Mucosight AI, an oral cancer screening tool from Kyushu University.
It analyzes mouth photos in about 30 seconds to flag suspicious lesions.
It is expected to enter clinical use this August.
What happened
Kyushu University announced that its AI-based medical device, the oral mucosal image analysis system Mucosight AI, received regulatory approval from Japan's Ministry of Health, Labour and Welfare on August 4, 2026.
Why it matters
The AI analyzes photos of the mouth to flag suspicious lesions indicative of oral cancer, potentially helping dentists—who are the target users—decide when to refer patients to specialized care. NVIDIA supported development with technical expertise and computing resources.
What to watch
The system returns results in about 30 seconds, and clinical implementation is expected to begin in August this year.
Ask the AI about this article →
Kyushu University's development of Mucosight AI began as a research project that combined knowledge dating back to 2017. With NVIDIA support starting in 2018, the team refined the model using a supercomputer named Octopus and SQUID. The system was trained on over four years of oral mucosal images, including confirmed cases. The approval marks the culmination of this long-term collaboration. The device is classified as software as a medical device (SaMD), reflecting a growing trend of AI in diagnostic support. Its ability to output results within 30 seconds could ease the burden on dentists, who may struggle to distinguish early-stage oral cancer from other conditions. However, it is not a definitive diagnostic tool; rather, it aids referral decisions.
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · takes 30 seconds · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
Osaka University and colleagues received regulatory approval from Japan's health ministry for an AI diagnostic…
Reuters reports Huawei's healthcare president said the company plans more AI pharma tie-ups
Astellas Pharma has adopted NVIDIA's Boltz-2 NIM, an AI-powered platform that predicts biomolecular structures…
SORA Technology has officially launched a malaria elimination project in Zanzibar, Tanzania, using satellite d…
Cigna projects its AI and predictive analytics tools, used to identify chronic conditions like cancer and kidn…
Legato, a hearing tech startup founded by two Bose veterans, emerged from stealth with $12 million in funding…
